Eculizumab improves fatigue in refractory generalized myasthenia gravis

被引：0
|
作者：
Henning Andersen
Renato Mantegazza
Jing Jing Wang
Fanny O’Brien
Kaushik Patra
James F. Howard
机构：
[1] Aarhus University Hospital,Department of Neurology
[2] IRCCS,Foundation of the Carlo Besta Neurological Institute
[3] Formerly of Alexion Pharmaceuticals,Department of Neurology, UNC School of Medicine
[4] Inc.,undefined
[5] Alexion Pharmaceuticals,undefined
[6] Inc.,undefined
[7] University of North Carolina at Chapel Hill,undefined
来源：
Quality of Life Research | 2019年 / 28卷
关键词：
Eculizumab; Myasthenia gravis; Fatigue; Neuro-QOL Fatigue; Quality of life; Terminal complement inhibition; Complement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2247 / 2254
页数：7
相关论文
共 50 条
  • [1] Eculizumab improves fatigue in refractory generalized myasthenia gravis
    Andersen, Henning
    Mantegazza, Renato
    Wang, Jing Jing
    O'Brien, Fanny
    Patra, Kaushik
    Howard, James F., Jr.
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 (08) : 2247 - 2254
  • [2] Eculizumab improves fatigue in patients with refractory generalized myasthenia gravis in the REGAIN study
    Andersen, H.
    Mantegazza, R.
    Derosier, F.
    Wang, J. J.
    Zhang, J.
    Howard, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 498 - 498
  • [3] Eculizumab in the Treatment of Seronegative Refractory Generalized Myasthenia Gravis
    Singh, Shivangi
    Singh, Harsh
    Datta, Sorabh
    Govindarajan, Raghav
    [J]. NEUROLOGY, 2020, 94 (15)
  • [4] Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis
    Oyama, Munenori
    Okada, Kensuke
    Masuda, Masayuki
    Shimizu, Yuko
    Yokoyama, Kazumasa
    Uzawa, Akiyuki
    Kawaguchi, Naoki
    Ikeguchi, Ryotaro
    Hoshino, Yasunobu
    Hatano, Taku
    Ozawa, Yukiko
    Nakahara, Jin
    Aizawa, Hitoshi
    Kitagawa, Kazuo
    Hattori, Nobutaka
    Kuwabara, Satoshi
    Murai, Hiroyuki
    Suzuki, Shigeaki
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [5] POOR RESPONSE TO ECULIZUMAB IN PATIENTS WITH TREATMENT REFRACTORY GENERALIZED MYASTHENIA GRAVIS
    Katyal, Nakul
    Govindarajan, Raghav
    [J]. MUSCLE & NERVE, 2022, 66 : S13 - S13
  • [6] Eculizumab: A Review in Generalized Myasthenia Gravis
    Dhillon, Sohita
    [J]. DRUGS, 2018, 78 (03) : 367 - 376
  • [7] Eculizumab: A Review in Generalized Myasthenia Gravis
    Sohita Dhillon
    [J]. Drugs, 2018, 78 : 367 - 376
  • [8] EFFICACY AND SAFETY OF ECULIZUMAB IN REFRACTORY GENERALIZED MYASTHENIA GRAVIS - A PROSPECTIVE CASE SERIES
    Siddiqi, Zaeem A.
    Blackmore, Derrick
    Alvi, Muhammad
    Hussain, Faraz
    [J]. MUSCLE & NERVE, 2022, 65 : S40 - S40
  • [9] Role of Eculizumab in Treatment Refractory Myasthenia Gravis
    Mishra, Shri
    Khosa, Shaweta
    Freundlich, Robert
    Vazirian, Samra
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S113 - S113
  • [10] Correction to: Eculizumab: A Review in Generalized Myasthenia Gravis
    Sohita Dhillon
    [J]. Drugs, 2018, 78 (5) : 607 - 607
12345